Here is a cover-length editorial on the virtues of GLP-1 receptor agonists, such as Ozempic and Wegovy. Dedicated readers will recognise it from our edition of October 26th 2024. We would like you ...

I also have news of a competition to design your own cover for The Economist, but more on that later. Although we rarely put Africa on our cover, demography is making the continent more important ...